ALTEROLA BIOTECH INC. Quarterly Deferred Income Tax Assets, Net in USD from Q2 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
Alterola Biotech Inc. quarterly Deferred Income Tax Assets, Net history and growth rate from Q2 2022 to Q3 2023.
  • Alterola Biotech Inc. Deferred Income Tax Assets, Net for the quarter ending September 30, 2023 was $187K, a 41.9% increase year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $187K +$55.2K +41.9% Sep 30, 2023 10-Q 2023-11-21
Q2 2023 $194K +$150K +340% Jun 30, 2023 10-Q 2023-08-15
Q1 2023 $189K Mar 31, 2023 10-Q/A 2024-02-21
Q4 2022 $143K Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $132K Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $44K Jun 30, 2022 10-Q 2022-08-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.